Trials / Unknown
UnknownNCT04695015
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish a standardized process for obtaining digital pathological image information of ocular tumors; use modern pathological techniques to obtain the co-expression information of multiple biomarkers in the pathological tissues of ocular tumors, and finally construct standardized digital ocular tumors with biomarkers Pathology image database.
Detailed description
This study is a prospective study. Patients with common and representative ocular tumors in the Department of Ophthalmology, Peking University Third Hospital, will be selected and enrolled after informed consent to collect basic clinical information, preoperative blood samples, and ocular tumors Obtain pathological image annotation data and genomics-related data from ocular tumor tissue specimens, use blood samples for genomics information analysis, provide multi-dimensional data for the development of artificial intelligence algorithms, and establish artificial intelligence-assisted image data for eye tumors Standardize the process and establish a multi-modal ocular tumor standardized database of "clinical information-tissue samples-pathological images-genomics data". The database and the diagnosis system are correlated with each other to provide optimal image data for later machine learning and related algorithm establishment, and finally the investigators will be completed the design of a new artificial intelligence-assisted diagnosis system for eye tumors.
Conditions
- Melanoma (Skin)
- Melanoma in Situ
- Nevus Eye
- Sebaceous Gland Carcinoma of the Eyelid
- Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Ocular Tumor
Timeline
- Start date
- 2020-12-31
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2021-01-05
- Last updated
- 2021-01-05
Source: ClinicalTrials.gov record NCT04695015. Inclusion in this directory is not an endorsement.